Patrick Hsu’s lab has developed an RNA-extraction-free test for rapid viral detection using saliva via a microfluidic device. The fast, accurate, and portable prototype shows potential as a point-of-care system to support frequent, on-site molecular diagnostics. This work was the August 2022 cover story for Nature Biomedical Engineering.
New work from Irina Conboy’s lab extends to humans their previous animal studies on age-specific differences in blood plasma, and establishes a novel direct measurement of biological age. Their results continue to demonstrate that aging may be driven by an excess of certain molecules and proteins, and point to potential treatments for age-related conditions.
Current Bioengineering Chair Sanjay Kumar has been selected to serve as the next director of the California Institute of Quantitative Biosciences at UC Berkeley (QB3-Berkeley) effective September 1, 2022. He will succeed David Schaffer, who was recently appointed as faculty director of the Bakar BioEnginuity Hub and executive director of QB3’s central office. Kumar will step down as Chair of the Department of Bioengineering effective September 1, where former Chair Dorian Liepmann will return to the role until a permanent appointment is made in 2023.
Professor Iain Clark, in partnership with graduate program faculty member Adam Abate, was able to analyze single cells harboring latent HIV using a technique that isolates single, infected cells as tiny amounts of blood move through their microfluidic devices. Their work was featured in Science news.
New research from the Conboy Lab, highlighted in New Scientist magazine, has demonstrated that transfusing young mice with blood from older rodents quickly triggers ageing in the young, suggesting that cellular ageing isn’t just a case of wear and tear. This is one step closer to potential anti-ageing treatments and builds on years of aging research from Professor Irina Conboy.
Synthetic biology startup Huue, founded by BioE PhD alumni Tammy Hsu, has raised $14.6 million in a Series A funding round for what it says is the world’s first clean and scalable indigo dye for denim.
Professor David Schaffer reflects on the reasons why he sees Berkeley as a leader in world-changing research, innovation and entrepreneurship.
A study led by Prof Patrick Hsu has identified specific proteins within our bodies that can promote or protect us from SARS-CoV-2 infections, potentially opening the door to new antiviral therapies. Notably, they showed that mucins — the main component of mucus found in the lungs — seem to help block the SARS-CoV-2 virus from entering cells.
New research led by Professor Jay Keasling took inspiration from an extraordinary antifungal molecule made by Streptomyces bacteria to develop a totally new type of fuel that has projected energy density greater than the most advanced heavy-duty fuels used today, including the rocket fuels used by NASA.